Lex H.T. Van der Ploeg
2018
In 2018, Lex H.T. Van der Ploeg earned a total compensation of $1.4M as Chief Scientific Officer at RHYTHM PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $147,594 |
|---|---|
| Option Awards | $866,250 |
| Salary | $383,361 |
| Total | $1,397,205 |
der Ploeg received $866.3K in option awards, accounting for 62% of the total pay in 2018.
der Ploeg also received $147.6K in non-equity incentive plan and $383.4K in salary.
Rankings
In 2018, Lex H.T. Van der Ploeg's compensation ranked 7,518th out of 14,244 executives tracked by ExecPay. In other words, der Ploeg earned more than 47.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,518 out of 14,244 | 47th |
Division Manufacturing | 2,918 out of 5,765 | 49th |
Major group Chemicals And Allied Products | 1,097 out of 2,128 | 48th |
Industry group Drugs | 927 out of 1,817 | 49th |
Industry Pharmaceutical Preparations | 729 out of 1,391 | 48th |
Source: SEC filing on April 30, 2019.
der Ploeg's colleagues
We found two more compensation records of executives who worked with Lex H.T. Van der Ploeg at RHYTHM PHARMACEUTICALS in 2018.